scispace - formally typeset
L

Lars Fugger

Researcher at John Radcliffe Hospital

Publications -  187
Citations -  19108

Lars Fugger is an academic researcher from John Radcliffe Hospital. The author has contributed to research in topics: Epitope & Major histocompatibility complex. The author has an hindex of 61, co-authored 176 publications receiving 16759 citations. Previous affiliations of Lars Fugger include University of Oxford & Aarhus University Hospital.

Papers
More filters
Journal ArticleDOI

Immunopathology of multiple sclerosis

TL;DR: The current understanding of multiple sclerosis immunopathology is discussed, long-standing hypotheses regarding the role of the immune system in the disease are evaluated, and key questions that are still unanswered are delineated.
Journal ArticleDOI

The Human Cell Atlas

Aviv Regev, +81 more
- 05 Dec 2017 - 
TL;DR: An open comprehensive reference map of the molecular state of cells in healthy human tissues would propel the systematic study of physiological states, developmental trajectories, regulatory circuitry and interactions of cells, and also provide a framework for understanding cellular dysregulation in human disease.
Journal ArticleDOI

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.

TL;DR: Observations suggest an enrichment of both IL-17+CD4+ and CD8+ T cells in active MS lesions as well as an important role for IL- 17 in MS pathogenesis, with some remarkable differences from the experimental autoimmune encephalomyelitis model.
Journal ArticleDOI

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice

TL;DR: The results indicate that the spontaneous response to β-cell antigens arises very early in life and that the anti-GAD immune response has a critical role in the disease process during this period.
Journal ArticleDOI

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

TL;DR: It is demonstrated that a T cell receptor from an MS patient recognized both a DRB1-restricted myelin basic protein (MBP) and DRB5*0101-restricted Epstein-Barr virus (EBV) peptide, providing structural evidence for molecular mimicry involving HLA molecules.